ACHILLES THERAPEUTICS PLC's ticker is ACHL and the CUSIP is 00449L102. A total of 19 filers reported holding ACHILLES THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,463,200 | -3.7% | 1,608,089 | 0.0% | 0.07% | +20.7% |
| Q2 2023 | $1,519,966 | -1.3% | 1,608,089 | 0.0% | 0.06% | -13.4% |
| Q1 2023 | $1,539,745 | +6.4% | 1,608,089 | 0.0% | 0.07% | +13.6% |
| Q4 2022 | $1,447,280 | -60.2% | 1,608,089 | 0.0% | 0.06% | -58.2% |
| Q3 2022 | $3,634,000 | -10.3% | 1,608,089 | 0.0% | 0.14% | -9.0% |
| Q2 2022 | $4,052,000 | -14.3% | 1,608,089 | 0.0% | 0.16% | +4.7% |
| Q1 2022 | $4,728,000 | -54.8% | 1,608,089 | -23.0% | 0.15% | -37.8% |
| Q4 2021 | $10,461,000 | -35.7% | 2,088,089 | 0.0% | 0.24% | -16.2% |
| Q3 2021 | $16,266,000 | -20.4% | 2,088,089 | 0.0% | 0.28% | -6.0% |
| Q2 2021 | $20,442,000 | -40.8% | 2,088,089 | 0.0% | 0.30% | -38.0% |
| Q1 2021 | $34,558,000 | – | 2,088,089 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 11,086,909 | $27,939,000 | 39.70% |
| RA Capital Management | 5,014,687 | $12,637,000 | 0.34% |
| Artal Group S.A. | 2,255,375 | $5,684,000 | 0.30% |
| Redmile Group, LLC | 1,608,089 | $4,052,000 | 0.16% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 242,978 | $612,000 | 0.15% |
| Orbimed Advisors | 1,584,845 | $3,994,000 | 0.07% |
| Baker Brothers Advisors | 2,591,366 | $6,530,000 | 0.04% |
| Point72 Asset Management, L.P. | 1,776,744 | $4,477,000 | 0.02% |
| Woodline Partners LP | 233,180 | $588,000 | 0.01% |
| AXA S.A. | 567,310 | $1,429,811 | 0.00% |